CTMX
#2689
CytomX Therapeutics, Inc. - Common Stock
3.3 1 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.22%
Changement Mensuel
+2.48%
Evolution sur 6 mois
-36.22%
Changement Annuel
+59.90%
Clôture Précédente
3.4 2
Open
3.3 0
Low
3.2 9
High
3.3 1
Volume
284
Financials
- Market Capitalization 721.25 M
- Employee 69
- Founded 2008
- CEO N/A
- Website www.cytomx.com
- Headquarter Delaware, United States
- FIGI BBG001J472L3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-33.83
ratio cours/chiffre d'affaires
7.71
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2684 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.99 USD | +0.56% | +1.93% | -24.58% | -27.85% | 727.30 M USD | ||
| 2688 |  STTK Shattuck Labs, Inc. - Common Stock | 7.19 USD | -6.01% | -1.37% | +4.96% | +619.00% | 721.61 M USD | ||
| 2703 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.75 USD | -4.68% | -4.06% | +1.27% | -9.33% | 701.52 M USD | ||
| 2704 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.03 USD | -2.87% | -2.40% | +16.67% | +72.03% | 701.35 M USD |